We are live on ! Find out more
EBACU

European Biotech Acquisition Corp. Units
EBACU

Delisted

EBACU was delisted on the 2nd of March, 2023.

Back to rankings

11 hedge funds and large institutions have $8M invested in European Biotech Acquisition Corp. Units in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

11% less capital invested

Capital invested by funds: $8.97M → $8M (-$975K)

39% less funds holding

Funds holding: 18 → 11 (-7)

78% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 9

Holders
11
Holders Change
-7
Holders Change %
-38.89%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
2
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$1.76M
2
Jane Street
Jane Street
New York
+$63K
3
CS
Clear Street
New York
+$30.8K

Top Sellers

Rank Fund Capital Flow
1
MTCM
Mint Tower Capital Management
Netherlands
-$991K
2
WC
Wealthspring Capital
New York
-$680K
3
SIA
Schechter Investment Advisors
Michigan
-$580K
4
CCA
Castle Creek Arbitrage
Colorado
-$317K
5
CSS
Cubist Systematic Strategies
Connecticut
-$148K
Name Holding Trade Value Shares
Change 		Change in
Stake
Millennium Management
1
Millennium Management
New York
$2.01M -$52K -5,190 -3%
Bank of Montreal
2
Bank of Montreal
Ontario, Canada
$1.78M +$1.76M +176,274 New
Jane Street
3
Jane Street
New York
$1.47M +$63K +6,293 +4%
HF
4
HRT Financial
New York
$755K – – –
Walleye Capital
5
Walleye Capital
New York
$733K – – –
Walleye Trading
6
Walleye Trading
New York
$504K – – –
CSS
7
Cubist Systematic Strategies
Connecticut
$346K -$148K -14,790 -30%
LCM
8
Landscape Capital Management
New Jersey
$307K – – –
CS
9
Clear Street
New York
$77K +$30.8K +3,078 +68%
TAM
10
Terrapin Asset Management
Florida
$6.04K +$6.01K +600 New
DCM
11
Dupont Capital Management
Delaware
$42 – – –
MTCM
12
Mint Tower Capital Management
Netherlands
– -$991K -100,000 Closed
WC
13
Wealthspring Capital
New York
– -$680K -68,613 Closed
SIA
14
Schechter Investment Advisors
Michigan
– -$580K -58,543 Closed
CCA
15
Castle Creek Arbitrage
Colorado
– -$317K -32,046 Closed
SMA
16
Sage Mountain Advisors
Georgia
– -$114K -11,530 Closed
WAM
17
Wolverine Asset Management
Illinois
– -$47K -4,759 Closed
UBS Group
18
UBS Group
Switzerland
– -$14K -1,384 Closed
CCM
19
Condor Capital Management
New Jersey
– -$13K -1,300 Closed

EBACU Hedge Fund Activity: Q4 2022 in Review

11 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Units (EBACU) for Q4 2022, worth a combined $8M — down 11% from $8.97M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of EBACU and 2 opened new positions — a net loss of 7 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Bank of Montreal, opening a new position worth an estimated $1.76M. The largest seller was Mint Tower Capital Management, exiting entirely with an estimated $991K sold.

  • 11 institutional investors held European Biotech Acquisition Corp. Units (EBACU) as of Q4 2022, down from 18 in Q3 2022.
  • Funds reported $8M of European Biotech Acquisition Corp. Units stock for Q4 2022, down 11% quarter-over-quarter.
  • 2 funds opened new European Biotech Acquisition Corp. Units positions in Q4 2022 and 9 closed out, a net change of -7 holders.
  • The largest European Biotech Acquisition Corp. Units buyer in Q4 2022 was Bank of Montreal, an estimated $1.76M added.
  • The largest European Biotech Acquisition Corp. Units seller in Q4 2022 was Mint Tower Capital Management, an estimated $991K sold.

Based on aggregated 13F filings for Q4 2022.